Lacosamide Injection, Solution
Product Images NDC 83854-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 83854-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

"image Description" (Fig 1 Laco Spl)

"image Description" (Fig 1 Laco Spl)
This is a summary of studies 3 and 4, reporting the seizure reduction and median percentage change from baseline with placebo and Lacosamide. The data indicate a statistically significant difference in seizure reduction with Lacosamide compared to placebo.*
FDA Label Image

"image Description" (Fig 2 Laco Spl)

"image Description" (Fig 2 Laco Spl)
This information consists of responder rates for different dosages of Lacosamide (200mg/day, 400mg/day, 600mg/day) and a placebo group. The data shows the percentage of patients experiencing improvement, worsening, and no change. There are sample sizes provided for each group to give context to the results.*
FDA Label Image

"image Description" (Fig 3 Laco Spl)

"image Description" (Fig 3 Laco Spl)
This text appears to be a statistical output related to a study or clinical trial. It includes information such as the proportion of patients, p-value, hazard ratio (HR) with risk reduction percentage, and a confidence interval for the hazard ratio. Additionally, it mentions the "Number of Risk" and a section titled "Time (Days)". It seems to be an analysis of patient outcomes over time.*
FDA Label Image

"image Description" (Spl Carton Label Lacosamide)

"image Description" (Spl Carton Label Lacosamide)
FDA Label Image

"image Description" (Spl Container Label Lacosamide)

"image Description" (Spl Container Label Lacosamide)
This text contains information about a medication with the NDC (National Drug Code) 83854-002-01 for intravenous use only. It includes a usual dosage recommendation, storage instructions, manufacturing details, and a caution to keep the product out of reach of children. The medication is Lacosamide and is provided in a 200 mg/20 mL single-dose vial. Additionally, it mentions that excursions in temperature are permitted according to specific temperature ranges.*
FDA Label Image

"image Description" (Structure Laco Spl)

"image Description" (Structure Laco Spl)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.